HK Stock Market Move | JBM HEALTHCARE (02161) rose by more than 5%, planning to acquire 90% stake in Tianxitang Pharmaceutical Factory for HKD 171 million.

JBM HEALTHCARE (02161) rises by over 5%, as of the time of writing, it is up by 5.56% to 1.9 Hong Kong dollars, with a trading volume of 2.9743 million Hong Kong dollars. On the news front, JBM HEALTHCARE announced on February 21 that its indirect wholly-owned subsidiary, Arrow King Inc., plans to acquire 90% of the issued shares of Tianxitang Pharmaceutical Factory Limited from Hou Jiasheng for a total consideration of 171 million Hong Kong dollars. It is reported that the target company mainly engages in the manufacturing, promotion, and sales of the branded Chinese medicine Tianxitang Tianxi Pill. The group believes that Tianxitang Tianxi Pill is a valuable high-quality brand, bringing important strategic value to the group's long-term business growth. The announcement stated that in order to fully leverage the brand potential, the group plans to conduct comprehensive marketing activities, using its mature brand management expertise to enhance brand awareness and strengthen consumer interaction. By expanding its distribution network and market coverage, the group will strive to tap into the potential of Tianxitang Tianxi Pill, expand untapped markets, and attract new customer groups.